Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

被引：0
|
作者：
Li Jiang
Jie Zhu
Xue Chen
Yi Wang
Lei Wu
Gang Wan
Yongtao Han
Xuefeng Leng
Lin Peng
Qifeng Wang
机构：
[1] University of Electronic Science and Technology of China,School of Medicine
[2] University of Electronic Science and Technology of China,Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine
[3] University of Electronic Science and Technology of China,Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine
来源：
Radiation Oncology | / 17卷
关键词：
Neoadjuvant chemoradiotherapy; Esophageal squamous cell carcinoma; Locally advanced esophageal squamous cell carcinoma; Carboplatin; Cisplatin; Paclitaxel; Adverse effects; Overall survival; Progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
    Jiang, Li
    Zhu, Jie
    Chen, Xue
    Wang, Yi
    Wu, Lei
    Wan, Gang
    Han, Yongtao
    Leng, Xuefeng
    Peng, Lin
    Wang, Qifeng
    [J]. RADIATION ONCOLOGY, 2022, 17 (01)
  • [2] Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
    Li Jiang
    Jie Zhu
    Xue Chen
    Yi Wang
    Lei Wu
    Gang Wan
    Yongtao Han
    Xuefeng Leng
    Lin Peng
    Qifeng Wang
    [J]. Radiation Oncology, 18
  • [3] Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study(vol 17, 218, 2022)
    Jiang, Li
    Zhu, Jie
    Chen, Xue
    Wang, Yi
    Wu, Lei
    Wan, Gang
    Han, Yongtao
    Leng, Xuefeng
    Peng, Lin
    Wang, Qifeng
    [J]. RADIATION ONCOLOGY, 2023, 18 (01)
  • [4] Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis
    Yi, Qiong
    Liu, Canyu
    Cui, Yingshan
    Yang, Yanguang
    Li, Yaqi
    Fan, Xingwen
    Wu, Kailiang
    [J]. CANCER MEDICINE, 2023, 12 (06): : 6477 - 6487
  • [5] Comparison of concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil versus cisplatin plus paclitaxel in patients with locally advanced cervical carcinoma
    Sol, Eui-Sok
    Lee, Tae Sung
    Koh, Suk Bong
    Oh, Hun Kyu
    Ye, Gi Won
    Choi, Youn Seok
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (01) : 28 - 34
  • [6] Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
    Jiang, Di Maria
    Sim, Hao-Wen
    Espin-Garcia, Osvaldo
    Chan, Bryan A.
    Natori, Akina
    Lim, Charles H.
    Moignard, Stephanie
    Chen, Eric X.
    Liu, Geoffrey
    Darling, Gail
    Swallow, Carol J.
    Brar, Savtaj
    Brierley, James
    Ringash, Jolie
    Wong, Rebecca
    Kim, John
    Rogalla, Patrik
    Hafezi-Bakhtiari, Sara
    Knox, Jennifer J.
    Jang, Raymond W.
    Elimova, Elena
    [J]. ONCOLOGY, 2021, 99 (01) : 49 - 56
  • [7] Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
    He, Wenwu
    Leng, Xuefeng
    Mao, Tianqin
    Luo, Xi
    Zhou, Lingxiao
    Yan, Jiaxin
    Peng, Lin
    Fang, Qiang
    Liu, Guangyuan
    Wei, Xing
    Wang, Kangning
    Wang, Chenghao
    Zhang, Sha
    Zhang, Xudong
    Shen, Xudong
    Huang, Depei
    Yi, Huan
    Bei, Ting
    She, Xueke
    Xiao, Wenguang
    Han, Yongtao
    [J]. ONCOLOGIST, 2022, 27 (01): : E18 - E28
  • [8] Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study
    Angioli, Roberto
    Plotti, Francesco
    Luvero, Daniela
    Aloisi, Alessia
    Guzzo, Federica
    Capriglione, Stella
    Terranova, Corrado
    Nardone, Carlo De Cicco
    Benedetti-Panici, Pierluigi
    [J]. TUMOR BIOLOGY, 2014, 35 (03) : 2741 - 2746
  • [9] Definitive chemoradiotherapy with Carboplatin Plus Paclitaxel for Unresectable Locally Advanced Thymic Carcinoma: A case series
    Nozaki, Koichiro
    Watanabe, Satoshi
    Yamazaki, Ryo
    Arita, Masashi
    Kikuchi, Toshiaki
    [J]. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 16
  • [10] A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma
    Wang, Hai-ying
    Yao, Zhi-hua
    Tang, Hong
    Zhao, Yan
    Jin, Shui-ling
    Zhou, Wen-ping
    Yao, Shu-na
    Yang, Shu-jun
    Liu, Yan-yan
    Luo, Su-xia
    [J]. ONCOTARGET, 2017, 8 (05) : 7540 - 7547
12345